Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 02, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and American Depository Shares (ADSs). It details transactions involving employee benefit trusts, personal equity plans, and share allocation awards for non-executive directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on equity transactions and share ownership changes rather than operational financial performance.
Material Changes and Transactions
- SmithKline Beecham Employee Benefit Trust: On December 24, 2002, 34,926 Ordinary shares were transferred from the Trust to participants of the 1991 Share Option Plan.
- Directors' Personal Equity Plan Purchases: On December 23, 2002, several directors acquired beneficial interests in Ordinary Shares at a price of £11.41 per share:
- Sir Christopher Hogg: 31 shares
- Mr J D Coombe: 9 shares
- Mrs G A Coombe: 7 shares
- Sir Peter Job: 2 shares
- GSK Trust Sale: On December 30, 2002, Abacus (GSK) Trustees Limited sold 3,590 Ordinary Shares at £11.4612 per share.
- US Retirement Savings Plan: On December 26, 2002, the number of Ordinary Share ADRs held by the fund increased from 18,284,894 to 18,343,751 at an average price of $36.60.
- Non-Executive Director Awards: On December 31, 2002, provisional allocations of Ordinary Shares and ADSs were made to non-executive directors for the period of October 1 to December 31, 2002, under automatic share allocation, share election, and annual dividend reinvestment arrangements.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory disclosure of shareholding changes and does not contain forward-looking statements or risk assessments.
Investor Verification Checklist
- Verify the total number of shares held by directors Dr J P Garnier and John Coombe through their interest in the SmithKline Beecham and GlaxoSmithKline Employee Benefit Trusts.
- Confirm the final settlement of the provisional share allocations for non-executive directors announced on December 31, 2002.
- Review the impact of the US Retirement Savings Plan's increase in ADR holdings on overall share ownership concentration.
- Check subsequent filings for the actual issuance of shares related to the Personal Equity Plan purchases made in late December 2002.